Integrative Genetic and Epigenetic Analysis Uncovers Regulatory Mechanisms of Autoimmune Disease

American Journal of Human Genetics

Volumn 101, Issue 1, 2017, Pages 75-86

  Shooshtari, Parisa ^a,b   Huang, Hailiang ^b,c   Cotsapas, Chris ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

DNase I hypersensitivity site; fine mapping; genome wide association study; non coding variation

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BASE PAIRING; DNA FOOTPRINTING; DNASE I HYPERSENSITIVE SITE; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; MATHEMATICAL PARAMETERS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ANTIBODY SPECIFICITY; CHROMOSOMAL MAPPING; CHROMOSOME 6; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INFLAMMATION; METABOLISM; REGULATORY SEQUENCE; REPRODUCIBILITY; RISK FACTOR;

DEOXYRIBONUCLEASE I;

ALLELES; AUTOIMMUNE DISEASES; CHROMOSOMES, HUMAN, PAIR 6; DEOXYRIBONUCLEASE I; EPIGENESIS, GENETIC; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; ORGAN SPECIFICITY; PHYSICAL CHROMOSOME MAPPING; REGULATORY SEQUENCES, NUCLEIC ACID; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 85026696904     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2017.06.001     Document Type: Article

References (59)

1. Zhernakova, A., van Diemen, C.C., Wijmenga, C., Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 10 (2009), 43–55.
2. Zenewicz, L.A., Abraham, C., Flavell, R.A., Cho, J.H., Unraveling the genetics of autoimmunity. Cell 140 (2010), 791–797.
3. Trynka, G., Sandor, C., Han, B., Xu, H., Stranger, B.E., Liu, X.S., Raychaudhuri, S., Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45 (2013), 124–130.
4. Maurano, M.T., Humbert, R., Rynes, E., Thurman, R.E., Haugen, E., Wang, H., Reynolds, A.P., Sandstrom, R., Qu, H., Brody, J., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337 (2012), 1190–1195.
5. Karczewski, K.J., Dudley, J.T., Kukurba, K.R., Chen, R., Butte, A.J., Montgomery, S.B., Snyder, M., Systematic functional regulatory assessment of disease-associated variants. Proc. Natl. Acad. Sci. USA 110 (2013), 9607–9612.
6. Corradin, O., Saiakhova, A., Akhtar-Zaidi, B., Myeroff, L., Willis, J., Cowper-Sal lari, R., Lupien, M., Markowitz, S., Scacheri, P.C., Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 24 (2014), 1–13.
7. Farh, K.K., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W.J., Beik, S., Shoresh, N., Whitton, H., Ryan, R.J., Shishkin, A.A., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518 (2015), 337–343.
8. Finucane, H.K., Bulik-Sullivan, B., Gusev, A., Trynka, G., Reshef, Y., Loh, P.R., Anttila, V., Xu, H., Zang, C., Farh, K., et al. ReproGen Consortium Schizophrenia Working Group of the Psychiatric Genomics Consortium, RACI Consortium. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47 (2015), 1228–1235.
9. Gusev, A., Lee, S.H., Trynka, G., Finucane, H., Vilhjálmsson, B.J., Xu, H., Zang, C., Ripke, S., Bulik-Sullivan, B., Stahl, E., et al. Schizophrenia Working Group of the Psychiatric Genomics Consortium SWE-SCZ Consortium Schizophrenia Working Group of the Psychiatric Genomics Consortium, SWE-SCZ Consortium. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am. J. Hum. Genet. 95 (2014), 535–552.
10. Liu, J.Z., Almarri, M.A., Gaffney, D.J., Mells, G.F., Jostins, L., Cordell, H.J., Ducker, S.J., Day, D.B., Heneghan, M.A., Neuberger, J.M., et al. UK Primary Biliary Cirrhosis (PBC) Consortium, Wellcome Trust Case Control Consortium 3. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 44 (2012), 1137–1141.
11. Kichaev, G., Pasaniuc, B., Leveraging functional-annotation data in trans-ethnic fine-mapping studies. Am. J. Hum. Genet. 97 (2015), 260–271.
12. Schaub, M.A., Boyle, A.P., Kundaje, A., Batzoglou, S., Snyder, M., Linking disease associations with regulatory information in the human genome. Genome Res. 22 (2012), 1748–1759.
13. Maller, J.B., McVean, G., Byrnes, J., Vukcevic, D., Palin, K., Su, Z., Howson, J.M., Auton, A., Myers, S., Morris, A., et al., Wellcome Trust Case Control Consortium. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 44 (2012), 1294–1301.
14. Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., et al. International Multiple Sclerosis Genetics Consortium (IMSGC) Wellcome Trust Case Control Consortium 2 (WTCCC2), International IBD Genetics Consortium (IIBDGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45 (2013), 1353–1360.
15. Huang, H., Fang, M., Jostins, L., Mirkov, M.U., Boucher, G., Anderson, C.A., Andersen, V., Cleynen, I., Cortes, A., Crins, F., et al. Association mapping of inflammatory bowel disease loci to single variant resolution. bioRxiv, 2015, 10.1101/028688.
16. Sheffield, N.C., Thurman, R.E., Song, L., Safi, A., Stamatoyannopoulos, J.A., Lenhard, B., Crawford, G.E., Furey, T.S., Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions. Genome Res. 23 (2013), 777–788.
17. Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stergachis, A.B., Wang, H., Vernot, B., et al. The accessible chromatin landscape of the human genome. Nature 489 (2012), 75–82.
18. Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M.A., Beaudet, A.L., Ecker, J.R., et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat. Biotechnol. 28 (2010), 1045–1048.
19. Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., Ziller, M.J., et al., Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518 (2015), 317–330.
20. John, S., Sabo, P.J., Thurman, R.E., Sung, M.H., Biddie, S.C., Johnson, T.A., Hager, G.L., Stamatoyannopoulos, J.A., Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43 (2011), 264–268.
21. Enright, A.J., Van Dongen, S., Ouzounis, C.A., An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 30 (2002), 1575–1584.
22. Patsopoulos, N.A., Esposito, F., Reischl, J., Lehr, S., Bauer, D., Heubach, J., Sandbrink, R., Pohl, C., Edan, G., Kappos, L., et al. Bayer Pharma MS Genetics Working Group Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist ANZgene Consortium GeneMSA, International Multiple Sclerosis Genetics Consortium. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 70 (2011), 897–912.
23. Liu, J.Z., van Sommeren, S., Huang, H., Ng, S.C., Alberts, R., Takahashi, A., Ripke, S., Lee, J.C., Jostins, L., Shah, T., et al. International Multiple Sclerosis Genetics Consortium, International IBD Genetics Consortium. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47 (2015), 979–986.
24. Cooper, J.D., Simmonds, M.J., Walker, N.M., Burren, O., Brand, O.J., Guo, H., Wallace, C., Stevens, H., Coleman, G., Franklyn, J.A., et al., Wellcome Trust Case Control Consortium. Seven newly identified loci for autoimmune thyroid disease. Hum. Mol. Genet. 21 (2012), 5202–5208.
25. Trynka, G., Hunt, K.A., Bockett, N.A., Romanos, J., Mistry, V., Szperl, A., Bakker, S.F., Bardella, M.T., Bhaw-Rosun, L., Castillejo, G., et al. Spanish Consortium on the Genetics of Coeliac Disease (CEGEC) PreventCD Study Group, Wellcome Trust Case Control Consortium (WTCCC). Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43 (2011), 1193–1201.
26. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A., et al., International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
27. Hinks, A., Cobb, J., Marion, M.C., Prahalad, S., Sudman, M., Bowes, J., Martin, P., Comeau, M.E., Sajuthi, S., Andrews, R., et al. Boston Children's JIA Registry British Society of Paediatric and Adolescent Rheumatology (BSPAR) Study Group Childhood Arthritis Prospective Study (CAPS) Childhood Arthritis Response to Medication Study (CHARMS) German Society for Pediatric Rheumatology (GKJR) JIA Gene Expression Study NIAMS JIA Genetic Registry TREAT Study, United Kingdom Juvenile Idiopathic Arthritis Genetics Consortium (UKJIAGC). Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat. Genet. 45 (2013), 664–669.
28. Tsoi, L.C., Spain, S.L., Knight, J., Ellinghaus, E., Stuart, P.E., Capon, F., Ding, J., Li, Y., Tejasvi, T., Gudjonsson, J.E., et al. Collaborative Association Study of Psoriasis (CASP) Genetic Analysis of Psoriasis Consortium Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44 (2012), 1341–1348.
29. Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., Suzuki, A., Yoshida, S., et al. RACI consortium, GARNET consortium. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 (2014), 376–381.
30. Onengut-Gumuscu, S., Chen, W.M., Burren, O., Cooper, N.J., Quinlan, A.R., Mychaleckyj, J.C., Farber, E., Bonnie, J.K., Szpak, M., Schofield, E., et al., Type 1 Diabetes Genetics Consortium. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47 (2015), 381–386.
31. Cordell, H.J., Han, Y., Mells, G.F., Li, Y., Hirschfield, G.M., Greene, C.S., Xie, G., Juran, B.D., Zhu, D., Qian, D.C., et al. Canadian-US PBC Consortium Italian PBC Genetics Study Group, UK-PBC Consortium. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat. Commun., 6, 2015, 8019.
32. Abecasis, G.R., Altshuler, D., Auton, A., Brooks, L.D., Durbin, R.M., Gibbs, R.A., Hurles, M.E., McVean, G.A., 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467 (2010), 1061–1073.
33. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. B 57 (1995), 289–300.
34. Chun, S., Casparino, A., Patsopoulos, N.A., Croteau-Chonka, D.C., Raby, B.A., De Jager, P.L., Sunyaev, S.R., Cotsapas, C., Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types. Nat. Genet. 49 (2017), 600–605.
35. Huber, W., Carey, V.J., Gentleman, R., Anders, S., Carlson, M., Carvalho, B.S., Bravo, H.C., Davis, S., Gatto, L., Girke, T., et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12 (2015), 115–121.
36. Maurano, M.T., Haugen, E., Sandstrom, R., Vierstra, J., Shafer, A., Kaul, R., Stamatoyannopoulos, J.A., Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo. Nat. Genet. 47 (2015), 1393–1401.
37. Ernst, J., Kellis, M., ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9 (2012), 215–216.
38. Cortes, A., Brown, M.A., Promise and pitfalls of the Immunochip. Arthritis Res. Ther., 13, 2011, 101.
39. Parkes, M., Cortes, A., van Heel, D.A., Brown, M.A., Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14 (2013), 661–673.
40. Moutsianas, L., Jostins, L., Beecham, A.H., Dilthey, A.T., Xifara, D.K., Ban, M., Shah, T.S., Patsopoulos, N.A., Alfredsson, L., Anderson, C.A., et al. International IBD Genetics Consortium (IIBDGC), International Multiple Sclerosis Genetics Consortium. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat. Genet. 47 (2015), 1107–1113.
41. Trynka, G., Westra, H.J., Slowikowski, K., Hu, X., Xu, H., Stranger, B.E., Klein, R.J., Han, B., Raychaudhuri, S., Disentangling the effects of colocalizing genomic annotations to functionally prioritize non-coding variants within complex-trait loci. Am. J. Hum. Genet. 97 (2015), 139–152.
42. De Jager, P.L., Baecher-Allan, C., Maier, L.M., Arthur, A.T., Ottoboni, L., Barcellos, L., McCauley, J.L., Sawcer, S., Goris, A., Saarela, J., et al. The role of the CD58 locus in multiple sclerosis. Proc. Natl. Acad. Sci. USA 106 (2009), 5264–5269.
43. Ellinghaus, D., Jostins, L., Spain, S.L., Cortes, A., Bethune, J., Han, B., Park, Y.R., Raychaudhuri, S., Pouget, J.G., Hübenthal, M., et al. International IBD Genetics Consortium (IIBDGC) International Genetics of Ankylosing Spondylitis Consortium (IGAS) International PSC Study Group (IPSCSG) Genetic Analysis of Psoriasis Consortium (GAPC), Psoriasis Association Genetics Extension (PAGE). Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48 (2016), 510–518.
44. Cotsapas, C., Voight, B.F., Rossin, E., Lage, K., Neale, B.M., Wallace, C., Abecasis, G.R., Barrett, J.C., Behrens, T., Cho, J., et al., FOCiS Network of Consortia. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet., 7, 2011, e1002254.
45. Bulik-Sullivan, B.K., Loh, P.R., Finucane, H.K., Ripke, S., Yang, J., Patterson, N., Daly, M.J., Price, A.L., Neale, B.M., Schizophrenia Working Group of the Psychiatric Genomics Consortium. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47 (2015), 291–295.
46. Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M., Smoller, J.W., Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14 (2013), 483–495.
47. Dendrou, C.A., Cortes, A., Shipman, L., Evans, H.G., Attfield, K.E., Jostins, L., Barber, T., Kaur, G., Kuttikkatte, S.B., Leach, O.A., et al. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci. Transl. Med., 8, 2016, 363ra149.
48. Skarnes, W.C., Rosen, B., West, A.P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A.O., Thomas, M., Harrow, J., Cox, T., et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474 (2011), 337–342.
49. Petkova, S.B., Yuan, R., Tsaih, S.W., Schott, W., Roopenian, D.C., Paigen, B., Genetic influence on immune phenotype revealed strain-specific variations in peripheral blood lineages. Physiol. Genomics 34 (2008), 304–314.
50. Frick, A., Fedoriw, Y., Richards, K., Damania, B., Parks, B., Suzuki, O., Benton, C.S., Chan, E., Thomas, R.S., Wiltshire, T., Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics. Pharm. Genomics Pers. Med. 8 (2015), 81–98.
51. Petrovski, S., Wang, Q., Heinzen, E.L., Allen, A.S., Goldstein, D.B., Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet., 9, 2013, e1003709.
52. Lek, M., Karczewski, K.J., Minikel, E.V., Samocha, K.E., Banks, E., Fennell, T., O'Donnell-Luria, A.H., Ware, J.S., Hill, A.J., Cummings, B.B., et al., Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536 (2016), 285–291.
53. Matsuo, Y., Azuma, Y.T., Kuwamura, M., Kuramoto, N., Nishiyama, K., Yoshida, N., Ikeda, Y., Fujimoto, Y., Nakajima, H., Takeuchi, T., Interleukin 19 reduces inflammation in chemically induced experimental colitis. Int. Immunopharmacol. 29 (2015), 468–475.
54. Azuma, Y.T., Matsuo, Y., Kuwamura, M., Yancopoulos, G.D., Valenzuela, D.M., Murphy, A.J., Nakajima, H., Karow, M., Takeuchi, T., Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm. Bowel Dis. 16 (2010), 1017–1028.
55. Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Granados, J., Yamamoto-Furusho, J.K., Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study. Clin. Exp. Immunol. 177 (2014), 64–75.
56. Azuma, Y.T., Nakajima, H., Takeuchi, T., IL-19 as a potential therapeutic in autoimmune and inflammatory diseases. Curr. Pharm. Des. 17 (2011), 3776–3780.
57. Davison, L.J., Wallace, C., Cooper, J.D., Cope, N.F., Wilson, N.K., Smyth, D.J., Howson, J.M., Saleh, N., Al-Jeffery, A., Angus, K.L., et al., Cardiogenics Consortium. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum. Mol. Genet. 21 (2012), 322–333.
58. Kircher, M., Witten, D.M., Jain, P., O'Roak, B.J., Cooper, G.M., Shendure, J., A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46 (2014), 310–315.
59. Petrovski, S., Gussow, A.B., Wang, Q., Halvorsen, M., Han, Y., Weir, W.H., Allen, A.S., Goldstein, D.B., The intolerance of regulatory sequence to genetic variation predicts gene dosage sensitivity. PLoS Genet., 11, 2015, e1005492.